.Nature Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint requires incorporation of clients with MASLD and measurement of liver results in cardio-- kidney-- metabolic trials, when data propose mechanistically conceivable benefits and also medical safety and security-- as well as describes factors to consider for test style as well as regulatory approval.